Artemis Medicare Services542919Board meeting scheduled
Board meeting on October 30, 2026 to approve September quarter results
Board meeting scheduled for October 30, 2026 (Friday).
By ScoutQuest · · 1 min read
- Board Meeting Date
- October 30, 2026 (Friday)
- Agenda Period
- quarter/half year ended September 30, 2026
- Trading Window Closure
- closed from October 1, 2026 up to November 1, 2026 (both days inclusive)
What was announced
- A meeting of the Board of Directors will be held on October 30, 2026 (Friday).
- The agenda is to consider and approve the Un-audited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30, 2026.
- The intimation was given to the National Stock Exchange and BSE under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Trading window
- The trading window for dealing in the company's securities was closed from October 1, 2026.
- It shall remain closed till 48 hours after the declaration of the Un-audited financial results, that is up to November 1, 2026 (both days inclusive).
- This means designated persons covered by the company's insider trading rules cannot deal in the shares during this period.
Why this matters to a retail investor
- A board meeting to approve quarterly and half-yearly results is a regular, scheduled event for a listed company. It marks the date on which the company's numbers for the July to September 2026 period are expected to be formally taken on record.
- Results for a half year also cover the first six months of the financial year, so the disclosures may include both the three-month and the six-month picture.
- The trading window closure runs on a fixed timeline linked to the results declaration, and the company has stated the end date as November 1, 2026.
What to watch
- The Un-audited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30, 2026, which the Board will consider and approve at the meeting.
- Any other matter that the Board takes up at the same meeting, as per the stated agenda.
Also from Artemis Medicare Services
Artemis Medicare schedules Q2 and H1 FY27 earnings conference call for November 2, 2026, hosted by Anand Rathi Research
27 Oct 2026
GST Show Cause Notice of Rs. 11.11 Crore Received for FY 2022-23
29 Sep 2026
More numbers
- Trading window closure period after results declaration48 hours
Source: BSE · 27 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.